SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-23-001558
Filing Date
2023-12-01
Accepted
2023-11-30 19:47:56
Documents
12
Period of Report
2023-12-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g083874_8k.htm   iXBRL 8-K 35924
  Complete submission text file 0001753926-23-001558.txt   212271

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lipo-20231201.xsd EX-101.SCH 3012
3 XBRL LABEL FILE lipo-20231201_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lipo-20231201_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT g083874_8k_htm.xml XML 3471
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 231457176
SIC: 2834 Pharmaceutical Preparations